vs
Oil-Dri Corp of America（ODC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Oil-Dri Corp of America的1.6倍（$197.9M vs $120.5M），Oil-Dri Corp of America净利率更高（12.8% vs 6.7%，领先6.1%），REPLIGEN CORP同比增速更快（13.6% vs -5.8%），REPLIGEN CORP自由现金流更多（$17.6M vs $1.3M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.8%）
美国Oil-Dri公司是专业吸附剂及黏土基产品生产商，主营工业溢油清理吸附材料、猫砂等宠物护理产品、农业土壤改良剂及运动场场地调理材料，客户覆盖北美及全球多个商业领域。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ODC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$120.5M
营收增速更快
RGEN
高出19.5%
-5.8%
净利率更高
ODC
高出6.1%
6.7%
自由现金流更多
RGEN
多$16.3M
$1.3M
两年增速更快
RGEN
近两年复合增速
6.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.5M | $197.9M |
| 净利润 | $15.5M | $13.3M |
| 毛利率 | 29.5% | 52.5% |
| 营业利润率 | 14.1% | 9.0% |
| 净利率 | 12.8% | 6.7% |
| 营收同比 | -5.8% | 13.6% |
| 净利润同比 | -5.6% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ODCRGEN
| Q4 25 | $120.5M | $197.9M | ||
| Q3 25 | $125.2M | $188.8M | ||
| Q2 25 | $115.5M | $182.4M | ||
| Q1 25 | $116.9M | $169.2M | ||
| Q4 24 | $127.9M | $174.1M | ||
| Q3 24 | $113.7M | $154.9M | ||
| Q2 24 | $106.8M | $154.1M | ||
| Q1 24 | $105.7M | $151.3M |
净利润ODCRGEN
| Q4 25 | $15.5M | $13.3M | ||
| Q3 25 | $13.1M | $14.9M | ||
| Q2 25 | $11.6M | $14.9M | ||
| Q1 25 | $12.9M | $5.8M | ||
| Q4 24 | $16.4M | $-30.3M | ||
| Q3 24 | $8.5M | $-654.0K | ||
| Q2 24 | $7.8M | $3.3M | ||
| Q1 24 | $12.4M | $2.1M |
毛利率ODCRGEN
| Q4 25 | 29.5% | 52.5% | ||
| Q3 25 | 27.8% | 53.2% | ||
| Q2 25 | 28.6% | 50.0% | ||
| Q1 25 | 29.5% | 53.6% | ||
| Q4 24 | 31.9% | 26.1% | ||
| Q3 24 | 29.0% | 50.0% | ||
| Q2 24 | 28.2% | 49.8% | ||
| Q1 24 | 29.3% | 49.5% |
营业利润率ODCRGEN
| Q4 25 | 14.1% | 9.0% | ||
| Q3 25 | 12.5% | 8.9% | ||
| Q2 25 | 12.0% | 7.6% | ||
| Q1 25 | 15.0% | 3.9% | ||
| Q4 24 | 16.6% | -17.7% | ||
| Q3 24 | 11.3% | -5.1% | ||
| Q2 24 | 9.8% | 1.0% | ||
| Q1 24 | 14.4% | 1.3% |
净利率ODCRGEN
| Q4 25 | 12.8% | 6.7% | ||
| Q3 25 | 10.4% | 7.9% | ||
| Q2 25 | 10.1% | 8.2% | ||
| Q1 25 | 11.1% | 3.4% | ||
| Q4 24 | 12.8% | -17.4% | ||
| Q3 24 | 7.5% | -0.4% | ||
| Q2 24 | 7.3% | 2.2% | ||
| Q1 24 | 11.7% | 1.4% |
每股收益（稀释后）ODCRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $266.5M | $2.1B |
| 总资产 | $380.7M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ODCRGEN
| Q4 25 | $42.4M | $767.6M | ||
| Q3 25 | $50.5M | $748.7M | ||
| Q2 25 | $36.5M | $708.9M | ||
| Q1 25 | $22.6M | $697.2M | ||
| Q4 24 | $12.5M | $757.4M | ||
| Q3 24 | $23.5M | $784.0M | ||
| Q2 24 | $46.8M | $809.1M | ||
| Q1 24 | $27.8M | $780.6M |
总债务ODCRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ODCRGEN
| Q4 25 | $266.5M | $2.1B | ||
| Q3 25 | $259.1M | $2.1B | ||
| Q2 25 | $246.9M | $2.1B | ||
| Q1 25 | $235.9M | $2.0B | ||
| Q4 24 | $224.0M | $2.0B | ||
| Q3 24 | $210.6M | $2.0B | ||
| Q2 24 | $202.9M | $2.0B | ||
| Q1 24 | $196.0M | $2.0B |
总资产ODCRGEN
| Q4 25 | $380.7M | $2.9B | ||
| Q3 25 | $391.7M | $2.9B | ||
| Q2 25 | $369.5M | $2.9B | ||
| Q1 25 | $353.7M | $2.9B | ||
| Q4 24 | $350.2M | $2.8B | ||
| Q3 24 | $354.6M | $2.8B | ||
| Q2 24 | $319.2M | $2.9B | ||
| Q1 24 | $296.2M | $2.8B |
负债/权益比ODCRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $1.3M | $17.6M |
| 自由现金流率自由现金流/营收 | 1.1% | 8.9% |
| 资本支出强度资本支出/营收 | 7.5% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.67× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $50.8M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ODCRGEN
| Q4 25 | $10.3M | $25.7M | ||
| Q3 25 | $25.2M | $48.1M | ||
| Q2 25 | $22.7M | $28.6M | ||
| Q1 25 | $21.4M | $15.0M | ||
| Q4 24 | $10.9M | $39.2M | ||
| Q3 24 | $23.4M | $49.3M | ||
| Q2 24 | $19.0M | $42.2M | ||
| Q1 24 | $9.4M | $44.7M |
自由现金流ODCRGEN
| Q4 25 | $1.3M | $17.6M | ||
| Q3 25 | $17.1M | $43.4M | ||
| Q2 25 | $16.0M | $21.5M | ||
| Q1 25 | $16.4M | $11.4M | ||
| Q4 24 | $-1.9M | $33.6M | ||
| Q3 24 | $15.1M | $42.3M | ||
| Q2 24 | $10.8M | $37.4M | ||
| Q1 24 | $1.9M | $36.4M |
自由现金流率ODCRGEN
| Q4 25 | 1.1% | 8.9% | ||
| Q3 25 | 13.7% | 23.0% | ||
| Q2 25 | 13.8% | 11.8% | ||
| Q1 25 | 14.0% | 6.8% | ||
| Q4 24 | -1.5% | 19.3% | ||
| Q3 24 | 13.3% | 27.3% | ||
| Q2 24 | 10.1% | 24.3% | ||
| Q1 24 | 1.8% | 24.0% |
资本支出强度ODCRGEN
| Q4 25 | 7.5% | 4.1% | ||
| Q3 25 | 6.5% | 2.5% | ||
| Q2 25 | 5.8% | 3.9% | ||
| Q1 25 | 4.3% | 2.1% | ||
| Q4 24 | 10.0% | 3.2% | ||
| Q3 24 | 7.3% | 4.5% | ||
| Q2 24 | 7.7% | 3.1% | ||
| Q1 24 | 7.1% | 5.5% |
现金转化率ODCRGEN
| Q4 25 | 0.67× | 1.93× | ||
| Q3 25 | 1.93× | 3.23× | ||
| Q2 25 | 1.95× | 1.92× | ||
| Q1 25 | 1.66× | 2.57× | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 2.74× | — | ||
| Q2 24 | 2.44× | 12.70× | ||
| Q1 24 | 0.76× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ODC
| Cat Litter | $64.6M | 54% |
| Fluids Purification | $26.7M | 22% |
| Agriculturaland Horticultural | $12.9M | 11% |
| Industrialand Sports | $11.6M | 10% |
| Animal Healthand Nutrition | $4.7M | 4% |
RGEN
暂无分部数据
